|
LRIG3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.877700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.208400E-01 |
| Normal-vs-Stage2 |
7.290400E-01 |
| Normal-vs-Stage3 |
1.157620E-01 |
| Normal-vs-Stage4 |
8.628800E-01 |
| Stage1-vs-Stage2 |
7.312800E-01 |
| Stage1-vs-Stage3 |
4.165800E-01 |
| Stage1-vs-Stage4 |
6.663600E-01 |
| Stage2-vs-Stage3 |
3.095000E-01 |
| Stage2-vs-Stage4 |
7.133800E-01 |
| Stage3-vs-Stage4 |
2.949800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.460300E-02 |
| Normal-vs-AfricanAmerican |
4.979600E-01 |
| Normal-vs-Asian |
8.208000E-01 |
| Caucasian-vs-AfricanAmerican |
5.206600E-01 |
| Caucasian-vs-Asian |
8.693800E-01 |
| AfricanAmerican-vs-Asian |
9.770000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.371800E-01 |
| Normal-vs-Female |
2.077100E-03 |
| Male-vs-Female |
4.222300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.000400E-01 |
| Normal-vs-Extreme_Weight |
5.929000E-01 |
| Normal-vs-Obese |
9.902000E-02 |
| Normal-vs-Extreme_Obese |
1.130170E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.063400E-01 |
| Normal_Weight-vs-Obese |
6.597800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.448850E-01 |
| Extreme_Weight-vs-Obese |
6.353600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.811560E-01 |
| Obese-vs-Extreme_Obese |
1.829860E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.641900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.579590E-02 |
| Normal-vs-Age(61-80Yrs) |
6.202000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.647800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.182600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.415600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.062100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.698300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.436300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.846600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.171800E-01 |
| Normal-VS-Type2 PRCC |
3.597000E-01 |
| Normal-VS-KIRP CIMP |
3.353500E-02 |
| Normal-VS-Unclassified PRCC |
5.918100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.022800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.962300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.035600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.913700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.681370E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.545800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.974600E-01 |
| Normal-vs-N1 |
3.016000E-01 |
| Normal-vs-N2 |
7.043400E-01 |
| N0-vs-N1 |
5.357000E-01 |
| N0-vs-N2 |
6.657600E-01 |
| N1-vs-N2 |
8.838200E-01 |
|
|
